53 related articles for article (PubMed ID: 19000993)
1. Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus.
Batuca JR; Ames PR; Amaral M; Favas C; Isenberg DA; Delgado Alves J
Rheumatology (Oxford); 2009 Jan; 48(1):26-31. PubMed ID: 19000993
[TBL] [Abstract][Full Text] [Related]
2. Air Pollution: Another Threat to HDL Function.
Ossoli A; Cetti F; Gomaraschi M
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613760
[TBL] [Abstract][Full Text] [Related]
3. Immune mechanisms associated with cardiovascular disease in systemic lupus erythematosus: A path to potential biomarkers.
Guzmán-Martínez G; Marañón C;
Front Immunol; 2022; 13():974826. PubMed ID: 36420265
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Cardiometabolic Risk Factors and Frailty in Older Adults: A Systematic Review.
Shakya S; Bajracharya R; Ledbetter L; Cary MP
Innov Aging; 2022; 6(5):igac032. PubMed ID: 35795135
[TBL] [Abstract][Full Text] [Related]
5. Bariatric Surgery Leads to a Reduction in Antibodies to Apolipoprotein A-1: a Prospective Cohort Study.
Adam S; Ho JH; Liu Y; Siahmansur T; Iqbal Z; Pagano S; Azmi S; Dhage SS; Donn R; Ammori BJ; Syed AA; Durrington PN; Malik RA; Vuilleumier N; Soran H
Obes Surg; 2022 Feb; 32(2):355-364. PubMed ID: 34888742
[TBL] [Abstract][Full Text] [Related]
6. The Roles of Lipoprotein in Psoriasis.
Shih CM; Chen CC; Chu CK; Wang KH; Huang CY; Lee AW
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013194
[TBL] [Abstract][Full Text] [Related]
7. IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients.
Sciascia S; Cecchi I; Radin M; Rubini E; Suárez A; Roccatello D; Rodríguez-Carrio J
Front Med (Lausanne); 2019; 6():211. PubMed ID: 31612138
[No Abstract] [Full Text] [Related]
8. Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy Subjects.
Vuilleumier N; Pagano S; Montecucco F; Quercioli A; Schindler TH; Mach F; Cipollari E; Ronda N; Favari E
J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31443207
[TBL] [Abstract][Full Text] [Related]
9. High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy.
Kim SY; Yu M; Morin EE; Kang J; Kaplan MJ; Schwendeman A
Arthritis Rheumatol; 2020 Jan; 72(1):20-30. PubMed ID: 31350818
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients.
Anderson JLC; Pagano S; Virzi J; Dullaart RPF; Annema W; Kuipers F; Bakker SJL; Vuilleumier N; Tietge UJF
J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31261925
[TBL] [Abstract][Full Text] [Related]
11. Serum lipid metabolism in psoriasis and psoriatic arthritis - an update.
Pietrzak A; Chabros P; Grywalska E; Kiciński P; Pietrzak-Franciszkiewicz K; Krasowska D; Kandzierski G
Arch Med Sci; 2019 Mar; 15(2):369-375. PubMed ID: 30899289
[TBL] [Abstract][Full Text] [Related]
12. Antibodies Against the C-Terminus of ApoA-1 Are Inversely Associated with Cholesterol Efflux Capacity and HDL Metabolism in Subjects with and without Type 2 Diabetes Mellitus.
Dullaart RPF; Pagano S; Perton FG; Vuilleumier N
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744100
[TBL] [Abstract][Full Text] [Related]
13. Identification of Levels of Serum Amyloid A and Apolipoprotein A1 in Serum Proteomic Analysis of Neuropsychiatric Systemic Lupus Erythematosus Patients.
Duarte-Delgado NP; Lujan TP; Arbeláez-Cortés Á; García-Valencia J; Zapata A; Rojas M; Restrepo-Escobar M; Vásquez G; Ortiz-Reyes BL
Autoimmune Dis; 2018; 2018():6728541. PubMed ID: 30584474
[TBL] [Abstract][Full Text] [Related]
14. Anti-High-Density Lipoprotein Antibodies and Antioxidant Dysfunction in Immune-Driven Diseases.
Rodríguez-Carrio J; Mozo L; López P; Nikiphorou E; Suárez A
Front Med (Lausanne); 2018; 5():114. PubMed ID: 29740582
[TBL] [Abstract][Full Text] [Related]
15. Psoriasis-associated vascular disease: the role of HDL.
Paiva-Lopes MJ; Delgado Alves J
J Biomed Sci; 2017 Sep; 24(1):73. PubMed ID: 28911329
[TBL] [Abstract][Full Text] [Related]
16. Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms.
Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Hartley O; Montecucco F; Mach F; Kutalik Z; Waeber G; Vollenweider P; Vuilleumier N
Front Immunol; 2017; 8():437. PubMed ID: 28458671
[TBL] [Abstract][Full Text] [Related]
17. Extended-release niacin increases anti-apolipoprotein A-I antibodies that block the antioxidant effect of high-density lipoprotein-cholesterol: the EXPLORE clinical trial.
Batuca JR; Amaral MC; Favas C; Paula FS; Ames PRJ; Papoila AL; Delgado Alves J
Br J Clin Pharmacol; 2017 May; 83(5):1002-1010. PubMed ID: 27891663
[TBL] [Abstract][Full Text] [Related]
18. Double positivity of the IgG isotype of both anticardiolipin and anti-β2gpI antibodies is associated with the highest number of vascular impairment parameters in patients with primary antiphospholipid syndrome: preliminary data.
Bećarević M; Mirković D; Ignjatović S
Clin Rheumatol; 2016 Dec; 35(12):2947-2954. PubMed ID: 27743141
[TBL] [Abstract][Full Text] [Related]
19. Anti-apolipoprotein A-I antibodies and paraoxonase 1 activity in Systemic Lupus Erythematosus.
Ahmed MM; Elserougy EM; Al-Gazzar II; Fikry IM; Habib DF; Younes KM; Salem NA
EXCLI J; 2013; 12():719-32. PubMed ID: 26622215
[TBL] [Abstract][Full Text] [Related]
20. Protective molecules and their cognate antibodies: new players in autoimmunity.
Zen M; Bassi N; Campana C; Bettio S; Tarricone E; Nalotto L; Ghirardello A; Doria A
Auto Immun Highlights; 2010 Nov; 1(2):63-72. PubMed ID: 26000109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
